Severe hemorrhage has posed a serious threat to the health and even life of civilian and
military populations and brought serious economic losses. Consequently, it is imperative to …

New evidence has stirred up a long‐standing but undeservedly forgotten interest in the role
of erythrocytes, or red blood cells (RBCs), in blood clotting and its disorders. This review …

In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of
intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity …

Red blood cells (RBCs) constitute a unique drug delivery system as a biologic or hybrid
carrier capable of greatly enhancing pharmacokinetics, altering pharmacodynamics (for …

In contrast to an obsolete notion that erythrocytes, or red blood cells (RBC s), play a passive
and minor role in haemostasis and thrombosis, over the past decades there has been …

The blood coagulation cascade is essential for haemostasis, but excessive activation can
cause thrombosis. Importantly, recent studies have identified factors that contribute to …

Cellular membrane‐derived nanoparticles, particularly of red blood cells (RBCs), represent
an emerging class of drug delivery systems. The lack of nucleus and organelles in these …

Red Blood Cells (RBCs) have been increasingly recognized to play important roles in
hemostasis and the mechanisms by which they do so continue to be elucidated. First and …

Storage lesion–induced, red cell–derived microvesicles (RBC-MVs) propagate coagulation
by supporting the assembly of the prothrombinase complex. It has also been reported that …

Microvesicles or ectosomes represent a major type of extracellular vesicles that are formed
by outward budding of the plasma membrane. Typically, they are bigger than exosomes but …